© BestSellerStuvia |
CHAMBERLAIN UNIVERSITY | COLLEGE OF NURSING
NR 341 | Pharmacology Clinical Judgment Exam
NR 341 — Pharmacology CJE
Pharmacology Clinical Judgment Exam (CJE)
INSTITUTION Chamberlain University | College of Nursing
PROGRAM Nursing (RN)
EXAM TITLE NR 341 Pharmacology Clinical Judgment Exam (CJE) 2026/2027 | Verified Questions
COURSE TITLE Pharmacology Clinical Judgment Exam (CJE)
COURSE CODE NR 341
ACADEMIC YEAR 2026/2027
TOTAL QUESTIONS 25 Questions
Core Domains: Pharmacokinetics & Pharmacodynamics • High-Alert Medications & Safety Protocols • Cardiovascular /
Respiratory Pharmacology • Endocrine Pharmacology • Neuro/Psych Pharmacology • Anti-Infectives & Antimicrobial Stewardship •
Pain Management & Palliative Pharmacology • Geriatric & Special Population Considerations
Entry-Level & Current Nursing Professional Focus
Multiple-Choice • Scenario Analysis • Applied Clinical Judgment Format
2026/2027 Edition — Aligned with the Chamberlain NR 341 Pharmacology Clinical Judgment Exam curriculum, NCSBN Clinical
Judgment Measurement Model, and evidence-based pharmacology standards
CONTENTS
Domain Content Area Questions
Domain 1 Pharmacokinetics & Pharmacodynamics 4
Domain 2 High-Alert Medications & Safety Protocols 4
Domain 3 Cardiovascular / Respiratory Pharmacology 5
Domain 4 Endocrine Pharmacology 3
Domain 5 Neuro/Psych Pharmacology 3
Domain 6 Anti-Infectives & Antimicrobial Stewardship 2
Domain 7 Pain Management & Palliative Pharmacology 2
Domain 8 Geriatric & Special Population Considerations 2
TOTAL All Domains 25
© BestSellerStuvia
Academic Year 2026/2027
NR 341 | 2026/2027
ACTUAL QUESTIONS
Domain 1: Pharmacokinetics & Pharmacodynamics
© BestSellerStuvia | | NR 341 | Academic Year 2026/2027
, © BestSellerStuvia |
Question 1. A client with hepatic impairment is prescribed a medication that undergoes extensive first-
pass metabolism. What is the most important nursing consideration?
A. Expect a delayed onset of action with no change in effect
B. Anticipate higher serum levels and increased risk of toxicity because of reduced first-pass metabolism
C. The drug will have no effect because of liver disease
D. Only renal dosing adjustments are ever needed
Correct Answer: D
Rationale: Hepatic impairment reduces first-pass metabolism, increasing bioavailability and raising the risk of toxicity
for high first-pass drugs.
Question 2. Which pharmacokinetic process is primarily responsible for terminating the action of most
drugs?
A. Absorption only
B. Metabolism and excretion (elimination)
C. Distribution alone
D. Receptor binding exclusively
Correct Answer: A
Rationale: Elimination through metabolism and excretion is the primary means by which drug action is terminated for
most medications.
Question 3. A drug has a narrow therapeutic index. What does this imply for nursing care?
A. Wide variation in dosing is always safe
B. Small differences in dose or blood level may lead to therapeutic failure or toxicity, requiring careful monitoring
C. No laboratory monitoring is ever needed
D. The drug can be administered without regard to timing
Correct Answer: B
Rationale: A narrow therapeutic index means the margin between effective and toxic concentrations is small, so
monitoring is critical.
Question 4. Which factor most directly affects the distribution of a highly protein-bound drug?
A. Only the client's age
B. Serum albumin level and competition from other protein-bound drugs
C. Only the route of administration
D. Only the time of day
Correct Answer: C
Rationale: Highly protein-bound drugs compete for albumin binding sites; low albumin or competing drugs increase
free (active) drug levels.
Domain 2: High-Alert Medications & Safety Protocols
Question 5. A client receiving continuous IV heparin has an aPTT of 110 seconds (control 30 seconds).
What is the priority nursing action?
A. Continue the infusion at the same rate
B. Stop the heparin infusion and notify the provider
C. Double the infusion rate
D. Administer an additional bolus of heparin
Correct Answer: D
Rationale: An aPTT of 110 seconds (well above the typical therapeutic range of 1.5–2.5 times control) indicates excessive
anticoagulation; the infusion should be stopped and the provider notified.
Question 6. What is the antidote for heparin overdose?
A. Vitamin K
B. Protamine sulfate
© BestSellerStuvia | | NR 341 | Academic Year 2026/2027
CHAMBERLAIN UNIVERSITY | COLLEGE OF NURSING
NR 341 | Pharmacology Clinical Judgment Exam
NR 341 — Pharmacology CJE
Pharmacology Clinical Judgment Exam (CJE)
INSTITUTION Chamberlain University | College of Nursing
PROGRAM Nursing (RN)
EXAM TITLE NR 341 Pharmacology Clinical Judgment Exam (CJE) 2026/2027 | Verified Questions
COURSE TITLE Pharmacology Clinical Judgment Exam (CJE)
COURSE CODE NR 341
ACADEMIC YEAR 2026/2027
TOTAL QUESTIONS 25 Questions
Core Domains: Pharmacokinetics & Pharmacodynamics • High-Alert Medications & Safety Protocols • Cardiovascular /
Respiratory Pharmacology • Endocrine Pharmacology • Neuro/Psych Pharmacology • Anti-Infectives & Antimicrobial Stewardship •
Pain Management & Palliative Pharmacology • Geriatric & Special Population Considerations
Entry-Level & Current Nursing Professional Focus
Multiple-Choice • Scenario Analysis • Applied Clinical Judgment Format
2026/2027 Edition — Aligned with the Chamberlain NR 341 Pharmacology Clinical Judgment Exam curriculum, NCSBN Clinical
Judgment Measurement Model, and evidence-based pharmacology standards
CONTENTS
Domain Content Area Questions
Domain 1 Pharmacokinetics & Pharmacodynamics 4
Domain 2 High-Alert Medications & Safety Protocols 4
Domain 3 Cardiovascular / Respiratory Pharmacology 5
Domain 4 Endocrine Pharmacology 3
Domain 5 Neuro/Psych Pharmacology 3
Domain 6 Anti-Infectives & Antimicrobial Stewardship 2
Domain 7 Pain Management & Palliative Pharmacology 2
Domain 8 Geriatric & Special Population Considerations 2
TOTAL All Domains 25
© BestSellerStuvia
Academic Year 2026/2027
NR 341 | 2026/2027
ACTUAL QUESTIONS
Domain 1: Pharmacokinetics & Pharmacodynamics
© BestSellerStuvia | | NR 341 | Academic Year 2026/2027
, © BestSellerStuvia |
Question 1. A client with hepatic impairment is prescribed a medication that undergoes extensive first-
pass metabolism. What is the most important nursing consideration?
A. Expect a delayed onset of action with no change in effect
B. Anticipate higher serum levels and increased risk of toxicity because of reduced first-pass metabolism
C. The drug will have no effect because of liver disease
D. Only renal dosing adjustments are ever needed
Correct Answer: D
Rationale: Hepatic impairment reduces first-pass metabolism, increasing bioavailability and raising the risk of toxicity
for high first-pass drugs.
Question 2. Which pharmacokinetic process is primarily responsible for terminating the action of most
drugs?
A. Absorption only
B. Metabolism and excretion (elimination)
C. Distribution alone
D. Receptor binding exclusively
Correct Answer: A
Rationale: Elimination through metabolism and excretion is the primary means by which drug action is terminated for
most medications.
Question 3. A drug has a narrow therapeutic index. What does this imply for nursing care?
A. Wide variation in dosing is always safe
B. Small differences in dose or blood level may lead to therapeutic failure or toxicity, requiring careful monitoring
C. No laboratory monitoring is ever needed
D. The drug can be administered without regard to timing
Correct Answer: B
Rationale: A narrow therapeutic index means the margin between effective and toxic concentrations is small, so
monitoring is critical.
Question 4. Which factor most directly affects the distribution of a highly protein-bound drug?
A. Only the client's age
B. Serum albumin level and competition from other protein-bound drugs
C. Only the route of administration
D. Only the time of day
Correct Answer: C
Rationale: Highly protein-bound drugs compete for albumin binding sites; low albumin or competing drugs increase
free (active) drug levels.
Domain 2: High-Alert Medications & Safety Protocols
Question 5. A client receiving continuous IV heparin has an aPTT of 110 seconds (control 30 seconds).
What is the priority nursing action?
A. Continue the infusion at the same rate
B. Stop the heparin infusion and notify the provider
C. Double the infusion rate
D. Administer an additional bolus of heparin
Correct Answer: D
Rationale: An aPTT of 110 seconds (well above the typical therapeutic range of 1.5–2.5 times control) indicates excessive
anticoagulation; the infusion should be stopped and the provider notified.
Question 6. What is the antidote for heparin overdose?
A. Vitamin K
B. Protamine sulfate
© BestSellerStuvia | | NR 341 | Academic Year 2026/2027
